Latest filing published 30 Dec 2025 for Enveric Biosciences, Inc.. Read the official filing
No signal scores available.
Marcus Schabacker discloses dealings in Enveric Biosciences, Inc. to SEC (Form 4). Over a trading history stretching from 9 October 2024 to 23 December 2025, the count stands at 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 30 December 2025: a share grant, in Enveric Biosciences, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations